Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT Jeremy Lee; Christopher J. Byrne; Paul N. Brennan; Iain MacPherson; Eleanor Dow; John F. Dillon;

From NAFLD to MASLD: When metabolic comorbidity matters Shan Hong; Lei Sun; Yiwei Hao; Ping Li; Yuling Zhou; Xiuxia Liang; Julong Hu; Hongshan Wei;

Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;